Trends in metabolic and bariatric surgery (MBS) procedure volume in the U.S. from 2015 to 2024 using MBSAQIP registry data, analyzed separately for adults (≥19 years) and adolescents (10–18 years) with a prespecified change point at 2022.
Among 1,970,021 MBS patients, adult volume grew ~3.94%/year from 2015–2022 (peak 229,826 in 2022) then fell ~11.29%/year through 2024 (176,915 procedures; p<0.001); adolescent volume rose ~10.53%/year through 2022 and continued rising without a significant post-2022 decline (p=0.98). Sleeve gastrectomy was most common (61.8%), followed by Roux-en-Y gastric bypass (27.7%).
MBSAQIP captures only accredited participating centers, not all U.S. MBS procedures; the number of participating centers changed over time and hospital-level identifiers are unavailable. No eligible-population denominator exists, preventing per-capita utilization estimates. Key potential confounders—GLP-1 RA use, insurance changes, referral patterns—are not captured in the registry.
Adult bariatric surgery volume has declined sharply since 2022, possibly related to the rise of GLP-1-based therapies, though causation cannot be established. Clinicians should monitor whether this trend persists, as it may signal shifting patient preferences or access barriers affecting who reaches surgical care.
Explore related topics